>Mercado europeu de software de rastreio do cancro do pulmão, por modo de entrega (soluções baseadas na nuvem, soluções locais e soluções baseadas na Web), produto (solução de radiologia de rastreio do cancro do pulmão, software de gestão de doentes de rastreio cancro do pulmão, software de gestão de nódulos, recolha de dados e relatórios, Coordenação e fluxo de trabalho do paciente, deteção assistida por computador de nódulos pulmonares, estadiamento de patologia e cancro, relatórios de auditoria estatística, PACs de rastreio, gestão de práticas e rastreio de registos de auditoria), tipo (triagem assistida por computador e triagem tradicional), aplicação (cancro do pulmão de células não pequenas (CPCNP) e Cancro do Pulmão de Pequenas Células (CPCP)), Plataforma (Autónoma e Integrada), Modalidade de Compra (Institucional e Individual), Utilizador Final (Centros de Oncologia, Hospitais, Blocos Operatórios de Ambulatório e Outros), Canal de Distribuição (Concurso Direto e Terceiros).
Análise e dimensão do mercado de software de rastreio do cancro do pulmão na Europa
O controlo das taxas de mortalidade por cancro do pulmão é uma das principais preocupações das unidades de saúde. As organizações públicas e privadas estão a tomar iniciativas para lançar programas de rastreio para controlar as taxas de mortalidade. Além disso, as empresas estão a lançar software avançado para facilitar a gestão dos dados dos pacientes e prestar melhores cuidados com diretrizes rigorosas de privacidade de dados.
O aumento da prevalência do cancro do pulmão, a crescente consciencialização das pessoas sobre o cancro do pulmão, o aumento das iniciativas governamentais e o número crescente de programas de rastreio são alguns dos principais factores que impulsionam o crescimento do mercado. Além disso, o avanço nas soluções baseadas em Inteligência Artificial (IA) e nas iniciativas estratégicas dos principais participantes do mercado estão a criar oportunidades na área do software de rastreio do cancro do pulmão.
No entanto, espera-se que as questões de privacidade de dados e falta de mão-de-obra não qualificada dificultem o crescimento do mercado no período de previsão.
A Data Bridge Market Research analisa que o mercado europeu de software de rastreio do cancro do pulmão deverá atingir o valor de 27.518,34 mil dólares até 2029, com um CAGR de 19,6% durante o período de previsão. As soluções baseadas na cloud são responsáveis pelo maior segmento de modo de entrega do mercado. O relatório de mercado abrange também análises de preços, análises de patentes e avanços tecnológicos em profundidade.
|
Métrica de relatório |
Detalhes |
|
Período de previsão |
2022 a 2029 |
|
Ano base |
2021 |
|
Anos históricos |
2020 (personalizável para 2019-2014) |
|
Unidades Quantitativas |
Receita em milhares de dólares, preço em dólares |
|
Segmentos cobertos |
By Mode of Delivery (Cloud Based Solutions, On-Premise Solutions and Web Based Solutions), Product (Lung Cancer Screening Radiology Solution, Lung Cancer Screening Patient Management Software, Nodule Management Software, Data Collection and Reporting, Patient Coordination and Workflow, Lung Nodule Computer Aided Detection, Pathology and Cancer Staging, Statistical Audit Reporting, Screening PACs, Practice Management and Audit Log Tracking), Type (Computer-Assisted Screening and Traditional Screening), Application (Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)), Platform (Standalone and Integrated), Purchase Mode (Institutional and Individual), End User (Oncology Centers, Hospitals, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender and Third Party Distributors) |
|
Countries Covered |
Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and rest of Europe |
|
Market Players Covered |
PenRad Technologies Inc., Koninklijke Philips N.V, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmbH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics, Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd, Median Technologies, AstraZeneca, and Aidence.com |
Market Definition
Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients’ participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate, and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.
Europe Lung Cancer Screening Software Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- Increase in prevalence of lung cancer cases globally
Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and acts as a driving factor for the market growth.
- Aumento da consciencialização sobre os benefícios do diagnóstico precoce e do rastreio frequente
Prevê-se que os crescentes programas de sensibilização para o cancro do pulmão por parte de organizações públicas, sem fins lucrativos e privadas impulsionem o crescimento do mercado. Estas iniciativas visam prevenir doenças, reduzir o estigma e o preconceito e promover a investigação. A consciencialização da população sobre o cancro do pulmão tem aumentado. Como existem muitos programas de sensibilização realizados por diferentes organizações, as pessoas sabem que o cancro do pulmão pode ser curado se for diagnosticado precocemente. Assim, a consciencialização das populações está a impulsionar o crescimento do mercado.
- Foram empreendidas iniciativas governamentais para implementar programas de rastreio de diversas doenças
O fardo do cancro continua a aumentar a nível mundial e provoca um grande stress financeiro, emocional e físico nos sistemas de saúde, nos produtos, nas famílias e nos indivíduos. Em países com sistemas de saúde fortes, a taxa de sobrevivência de muitos tipos de cancro melhora devido à sobrevivência, aos cuidados de qualidade, ao aumento da sensibilização e à detecção precoce acessível. Os Centros de Controlo e Prevenção de Doenças, os EUA, as tribos e as ilhas e territórios dos EUA-Pacífico, através do Programa Nacional Abrangente de Controlo do Cancro (NCCCP), devem formar ou apoiar alianças para combater o cancro nas suas comunidades . Com estas iniciativas, mais públicos são educados e mais conscientemente dispersos, incentivando o público global a ter mais cuidados e a praticar exames preventivos, promovendo o mercado.
- Número crescente de programas de rastreio em todo o mundo
O rastreio é um método eficaz para detetar o cancro numa fase inicial. Existe uma tendência crescente na incidência de cancro do pulmão nos países em desenvolvimento. Embora existam recomendações regulares para o rastreio do cancro da mama e do colo do útero, o mesmo não acontece no caso do cancro do pulmão. A maioria dos países ou instituições iniciou a viabilidade e o rastreio de doenças através da tomografia computorizada de baixa dose (LDCT) para o cancro do pulmão. O número crescente de rastreios de cancro do pulmão criou uma oportunidade para os participantes do mercado. Assim, a crescente taxa de diagnóstico atua como um fator impulsionador para o crescimento do mercado.
Oportunidade
-
Aumento das colaborações, fusões e aquisições entre os participantes do mercado
As empresas que operam no mercado estão a adotar diversas estratégias, incluindo fusões e aquisições, lançamentos de produtos, acordos, desenvolvimento de pipeline, colaborações e expansão de mercados, entre outras, para impulsionar os seus negócios em diversas dimensões. Espera-se que estas decisões estratégicas das empresas ofereçam oportunidades significativas para os players do mercado que operam no mercado.
Restrição/Desafio
- Problemas relacionados com a disponibilidade de software
Existem certas questões/barreiras relacionadas com o rastreio eficaz e eficiente do cancro do pulmão e a disponibilidade de software de rastreio do cancro do pulmão nos países em desenvolvimento. Os problemas são exigências concorrentes de tempo, conhecimento sobre o rastreio do cancro do pulmão, evolução das atitudes sobre a eficácia do rastreio, niilismo relacionado com resultados historicamente fracos do tratamento do cancro do pulmão e formação limitada e aprovação de requisitos para as autoridades locais ou para o organismo regulador de dispositivos médicos do país. Todas estas questões atrasam o lançamento e a disponibilidade do produto. Além disso, a procura de software de rastreio do cancro do pulmão é prejudicada devido a questões técnicas relacionadas com o software disponível, atuando assim como uma restrição ao crescimento do mercado.
Impacto pós-COVID-19 no mercado europeu de software de rastreio do cancro do pulmão
A COVID-19 criou um grande impacto em várias indústrias, uma vez que quase todos os países optaram pelo encerramento de todas as instalações, exceto as que lidam com o segmento dos bens essenciais. O governo tomou algumas medidas rigorosas, como o encerramento de instalações e a venda de bens não essenciais, o bloqueio do comércio internacional e muitas outras para impedir a propagação da COVID-19. O único negócio que funcionou durante esta situação de pandemia foram os serviços essenciais que puderam abrir e gerir os processos.
A COVID-19 criou novos e desconhecidos desafios para os prestadores de cuidados de saúde prestarem cuidados aos doentes. Muitos serviços não essenciais, mas importantes, como o rastreio do cancro do pulmão, foram temporariamente suspensos para proteger a saúde dos funcionários e dos doentes. As instituições de saúde enfrentaram desafios sem precedentes em termos de agendamento, monitorização dos doentes e acompanhamento da comunicação doente-serviço para garantir a continuidade dos cuidados durante a COVID-19 e quando os serviços pudessem ser continuados em segurança. A COVID-19 criou novos desafios para os programas de rastreio do cancro do pulmão, em muitos casos, atrasando o rastreio por vários meses e criando mais dificuldades para as equipas de gestão e agendamento. Embora a crise da COVID-19 tenha lançado uma nova luz sobre a importância da assistência respiratória, espera-se que tenha um grande impacto na redução do estigma do rastreio do cancro. Existem mais de 10 milhões de doentes elegíveis nos EUA que são elegíveis para rastreio do cancro do pulmão, menos de 5 por cento dos quais estão activamente inscritos no programa de rastreio. O COVID-19 criou um impacto negativo no mercado.
No entanto, as empresas de software de rastreio do cancro do pulmão estão a lutar e a tomar continuamente diferentes decisões estratégicas para controlar a situação. Os players estão envolvidos em atividades estratégicas como parcerias, colaborações e fusões e aquisições, entre outras, para melhorar a tecnologia envolvida no mercado. Com isto, as empresas trarão para o mercado soluções avançadas e precisas. Além disso, as iniciativas governamentais para impulsionar a digitalização em todas as indústrias também levaram ao crescimento do mercado.
Desenvolvimentos recentes
- Em julho de 2022, a GE Healthcare lançou o seu mais recente produto e ultrassons mais avançados, o Voluson Expert 22 de próxima geração. Esta última adição ao premiado portefólio de Saúde da Mulher da GE Healthcare utiliza tecnologia de formação de feixe baseada em gráficos, que produz imagens de maior qualidade e oferece maior flexibilidade nas funções de imagem. Com este produto, a empresa reforçou ainda mais a sua posição na área da prestação de produtos e serviços a instituições de saúde.
- Em outubro de 2021, a Thynk Health anunciou uma parceria com a Infervision, para combater o cancro do pulmão com as tecnologias mais avançadas do mundo. Oferece uma oportunidade para o rastreio do cancro do pulmão e tratamento de nódulos pulmonares. Com esta parceria, a empresa aumentou a sua presença no mercado.
Âmbito do mercado de software de rastreio do cancro do pulmão na Europa
O mercado europeu de software de rastreio do cancro do pulmão está segmentado em oito segmentos notáveis com base no modo de entrega, produto, tipo, aplicação, plataforma, modo de compra, utilizador final e canal de distribuição. O crescimento entre estes segmentos irá ajudá-lo a analisar segmentos de crescimento escasso nas indústrias e fornecer aos utilizadores uma valiosa visão geral do mercado e insights de mercado para os ajudar a tomar decisões estratégicas para identificar as principais aplicações do mercado.
Modo de entrega
- Soluções baseadas na nuvem
- Soluções locais
- Soluções baseadas na Web
Com base no modo de entrega, o mercado está segmentado em soluções baseadas na cloud, soluções locais e soluções baseadas na web.
Produto
- Solução de radiologia para rastreio de cancro de pulmão
- Software de gestão de doentes para rastreio de cancro de pulmão
- Software de gestão de nódulos
- Recolha de dados e relatórios
- Coordenação do doente e fluxo de trabalho
- Detecção assistida por computador de nódulo pulmonar
- Patologia e estadiamento do cancro
- Relatórios de auditoria estatística
- Triagem PACS
- Gestão Prática
- Acompanhamento de registo de auditoria
Com base no produto, o mercado está segmentado em solução de radiologia de rastreio do cancro do pulmão, software de gestão de doentes para rastreio do cancro do pulmão, software de gestão de nódulos, recolha e relatórios de dados, coordenação e fluxo de trabalho de doentes, deteção assistida por computador de nódulos pulmonares, patologia e estadiamento do cancro, relatórios de auditoria estatística, rastreio de PACS, gestão de práticas e rastreio de registos de auditoria.
Tipo
- Triagem assistida por computador
- Triagem Tradicional
Com base no tipo, o mercado está segmentado em triagem assistida por computador e triagem tradicional.
Aplicação
- Cancro do pulmão de células não pequenas (CPCNP)
- Cancro do Pulmão de Pequenas Células (SCLC)
Com base na aplicação, o mercado está segmentado em Cancro do Pulmão de Células Não Pequenas (NSCLC) e Cancro do Pulmão de Pequenas Células (SCLC).
Plataforma
- Autônomo
- Integrado
Com base na plataforma, o mercado está segmentado em autónomo e integrado.
Modo de compra
- Institucional
- Individual
Com base na modalidade de compra, o mercado está segmentado em individual e institucional.
Utilizador final
- Centros de Oncologia
- Hospitais
- Centros Cirúrgicos Ambulatoriais
- Outros
Com base no utilizador final, o mercado está segmentado em hospitais, centros oncológicos, centros de cirurgia ambulatória, entre outros.
Por canal de distribuição
- Concurso Direto
- Distribuidores terceirizados
Com base no canal de distribuição, o mercado está segmentado em licitação direta e distribuidores terceirizados.
Análise/perspetivas regionais do mercado de software de rastreio do cancro do pulmão na Europa
O mercado europeu de software de rastreio do cancro do pulmão é analisado e são fornecidos insights e tendências de tamanho de mercado com base no modo de entrega, produto, tipo, aplicação, plataforma, modo de compra, utilizador final e canal de distribuição. conforme acima mencionado.
Os países abrangidos neste relatório de mercado são a Alemanha, o Reino Unido, a França, a Itália, a Espanha, os Países Baixos, a Rússia, a Suíça, a Turquia, a Bélgica e o resto da Europa. A Alemanha domina o mercado, uma vez que o cancro do pulmão é a principal causa de morte por cancro na Europa, o que cria a necessidade de adoptar software de rastreio do cancro do pulmão para diagnóstico precoce. Além disso, o nível sofisticado predominante de instalações de saúde na região europeia também levou ao enorme crescimento do mercado na região.
A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, as tendências técnicas e a análise das cinco forças de Porter e estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas europeias e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e as rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Análise do panorama competitivo e da quota de mercado do software de rastreio do cancro do pulmão na Europa
O panorama competitivo do mercado europeu de software de rastreio do cancro do pulmão fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Europa, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.
Alguns dos principais players que operam no mercado são a PenRad Technologies Inc., Koninklijke Philips NV, Volpara Health Limited, Thynk Health, Nuance Communications, Inc., Siemens Healthcare GmBH, MyCareWare, Inc., MagView, MeVis Medical Solutions AG, Canon Medical Informatics , Inc., General Electric Company, Epic Systems Corporation, Lungview, Eon, Medtronic, Coreline Soft, Co., Ltd., Optellum Ltd, HealthMyne, Oncocyte Corporation, Genesystem, REVEALDX, FUJIFILM Holdings Corporation, F. Hoffmann-La Roche Ltd , Median Technologies, AstraZeneca e Aidence.com, entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of Europe lung cancer screening software market
- LIMITATION
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- market application coverage grid
- mode of delivery LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- premium insights
- REGULATIONS & REIMBURSEMENT
- IMPACT OF COVID-19 PANDEMIC ON THE MARKET
- Price impact
- Impact on demand
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISIONS FOR MANUFACTURERS
- CONCLUSION
- Market Overview
- drivers
- Increasing prevalence of lung cancer cases Europely
- Increasing awareness regarding the benefits of early diagnosis and frequent screening
- Government initiatives undertaken to implement screening programs for various diseases
- Growing number of screening programs across the globe
- Technological advancementS in THE field of healthcare
- RESTRAINTS
- issues related with the availability of software
- Scarcity of technically knowledgeable professionals for cancer diagnosis
- Lack of funding and other resources from various regions for cancer and associated disorders
- OPPORTUNITIES
- Rising collaborations, mergerS & acquisitions among the market players
- Increasing investmentS in healthcare segmentS
- Multiple benefits associated with lung cancer screening software
- CHALLENGES
- High cost of screening software and related services
- Increasing challenges related to development of lung cancer screening software
- Increasing competition in the market
- EUROPE lung cancer screening software MARKET, BY MODE OF DELIVERY
- overview
- Cloud Based Solutions
- On-Premise Solutions
- Web Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY PRODUCT
- overview
- Lung Cancer Screening Radiology Solution
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Cancer Screening Patient Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Nodule Management Software
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Data Collection and Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Patient Coordination and Workflow
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Lung Nodule Computer Aided Detection
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Pathology and Cancer Staging
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Statistical Audit Reporting
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Screening PACs
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Practice Management
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Audit Log Tracking
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY type
- overview
- Computer-Assisted Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Traditional Screening
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY application
- overview
- Non-Small Cell Lung Cancer (NSCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Small Cell Lung Cancer (SCLC)
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY platform
- overview
- Standalone
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- Integrated
- On-Premise Solutions
- Web Based Solutions
- Cloud Based Solutions
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Purchase Mode
- overview
- Institutional
- INDIVIDUAL
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY end user
- overview
- Oncology Centers
- Hospitals
- Ambulatory Surgical Centers
- Others
- EUROPE LUNG CANCER SCREENING SOFTWARE MARKET, BY Distribution Channel
- overview
- Direct Tenders
- Third Party Distributor
- Europe lung cancer screening software Market, by Geography
- Europe
- germany
- France
- U.K
- Italy
- SPAIN
- NETHERLANDS
- RUSSIA
- Switzerland
- BELGIUM
- Philippines
- Rest of Europe
- Europe Lung cancer screening software market, COMPANY landscape
- company share analysis: Europe
- Swot analysis
- CompanY profiles
- KONINKLIJKE PHILIPS N.v
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Nuance Communications, Inc.
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Siemens Healthcare GmbH
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Lungview
- COMPANY SNAPSHot
- company share analysis
- Solution Portfolio
- RECENT DEVELOPMENT
- Medtronic
- COMPANY SNAPSHot
- Revenue analysis
- company share analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Thynk health
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- Vital Images (A subsidiary of Canon Group Company)
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- MeVis Medical Solutions AG
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- HealthMyne
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- Volpara Solutions Limited
- COMPANY SNAPSHot
- Revenue analysis
- product Portfolio
- RECENT DEVELOPMENTS
- Coreline Soft, Co., Ltd.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- EON
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- MyCareWare Inc
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENT
- Optellum Ltd
- COMPANY SNAPSHot
- product Portfolio
- RECENT DEVELOPMENTS
- PenRad Technologies Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENT
- ProVation Medical, Inc.
- COMPANY SNAPSHot
- Solution Portfolio
- RECENT DEVELOPMENTS
- questionnaire
- related reports
Lista de Tabela
TABLE 1 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 2 Europe Cloud Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 3 Europe On-Premise Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 4 Europe Web Based Solutions in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand)
TABLE 5 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 6 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 7 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 8 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 9 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 10 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 11 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 12 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 13 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 14 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 15 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 16 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 17 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 18 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 19 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 20 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 21 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 22 Europe Screening PACs in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 23 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 24 Europe Practice Management in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 25 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 26 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 27 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 28 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 29 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 30 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 31 Europe Traditional Screening in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 32 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 33 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 34 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 35 Europe Non-Small Cell Lung Cancer (NSCLC) in Lung Cancer Screening Software Market, By Product Type, 2018-2027 (USD Thousand)
TABLE 36 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 37 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 38 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 39 Europe Standalone in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 40 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 41 Europe Integrated in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 42 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 43 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 44 Europe Institutional in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 45 Europe Individual in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 46 Europe Lung Cancer Screening Software Market, By end user, 2018-2027 (USD Thousand)
TABLE 47 Europe Oncology Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 48 Europe Hospitals in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 49 Europe Ambulatory Surgical Centers in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 50 Europe Others in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 51 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 52 Europe Direct Tenders in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 53 Europe Third Party Distributor in Lung Cancer Screening Software Market, By Region, 2018-2027 (USD Thousand )
TABLE 54 EUROPE LUNG CANCER SCREENING SOFTWARE market, By Country, 2018–2027 (USD thousand)
TABLE 55 Europe Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 56 Europe Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 57 Europe Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 58 Europe Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 59 Europe Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 60 Europe Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 61 Europe Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 62 Europe Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 63 Europe Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 64 Europe Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 65 Europe Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 66 Europe Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 67 Europe Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 68 Europe Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 69 Europe Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 70 Europe Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 71 Europe Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 72 Europe Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 73 Europe Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 74 Europe Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 75 Europe Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 76 Europe Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 77 Europe Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 78 Europe Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 79 Europe Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 80 Germany Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 81 Germany Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 82 Germany Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 83 Germany Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 84 Germany Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 85 Germany Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 86 Germany Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 87 Germany Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 88 Germany Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 89 Germany Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 90 Germany Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 91 Germany Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 92 Germany Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 93 Germany Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 94 Germany Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 95 Germany Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 96 Germany Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 97 Germany Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 98 Germany Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 99 Germany Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 100 Germany Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 101 Germany Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 102 Germany Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 103 Germany Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 104 Germany Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 105 France Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 106 France Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 107 France Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 108 France Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 109 France Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 110 France Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 111 France Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 112 France Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 113 France Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 114 France Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 115 France Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 116 France Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 117 France Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 118 France Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 119 France Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 120 France Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 121 France Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 122 France Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 123 France Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 124 France Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 125 France Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 126 France Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 127 France Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 128 France Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 129 France Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 130 U.K Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 131 U.K Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 132 U.K Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 133 U.K Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 134 U.K Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 135 U.K Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 136 U.K Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 137 U.K Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 138 U.K Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 139 U.K Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 140 U.K Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 141 U.K Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 142 U.K Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 143 U.K Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 144 U.K Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 145 U.K Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 146 U.K Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 147 U.K Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 148 U.K Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 149 U.K Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 150 U.K Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 151 U.K Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 152 U.K Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 153 U.K Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 154 U.K Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 155 Italy Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 156 Italy Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 157 Italy Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 158 Italy Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 159 Italy Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 160 Italy Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 161 Italy Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 162 Italy Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 163 Italy Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 164 Italy Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 165 Italy Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 166 Italy Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 167 Italy Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 168 Italy Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 169 Italy Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 170 Italy Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 171 Italy Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 172 Italy Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 173 Italy Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 174 Italy Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 175 Italy Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 176 Italy Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 177 Italy Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 178 Italy Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 179 Italy Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 180 Spain Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 181 Spain Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 182 Spain Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 183 Spain Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 184 Spain Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 185 Spain Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 186 Spain Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 187 Spain Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 188 Spain Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 189 Spain Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 190 Spain Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 191 Spain Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 192 Spain Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 193 Spain Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 194 Spain Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 195 Spain Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 196 Spain Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 197 Spain Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 198 Spain Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 199 Spain Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 200 Spain Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 201 Spain Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 202 Spain Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 203 Spain Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 204 Spain Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 205 Netherlands Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 206 Netherlands Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 207 Netherlands Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 208 Netherlands Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 209 Netherlands Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 210 Netherlands Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 211 Netherlands Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 212 Netherlands Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 213 Netherlands Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 214 Netherlands Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 215 Netherlands Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 216 Netherlands Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 217 Netherlands Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 218 Netherlands Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 219 Netherlands Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 220 Netherlands Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 221 Netherlands Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 222 Netherlands Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 223 Netherlands Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 224 Netherlands Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 225 Netherlands Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 226 Netherlands Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 227 Netherlands Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 228 Netherlands Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 229 Netherlands Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 230 Russia Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 231 Russia Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 232 Russia Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 233 Russia Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 234 Russia Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 235 Russia Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 236 Russia Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 237 Russia Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 238 Russia Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 239 Russia Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 240 Russia Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 241 Russia Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 242 Russia Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 243 Russia Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 244 Russia Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 245 Russia Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 246 Russia Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 247 Russia Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 248 Russia Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 249 Russia Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 250 Russia Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 251 Russia Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 252 Russia Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 253 Russia Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 254 Russia Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 255 Switzerland Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 256 Switzerland Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 257 Switzerland Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 258 Switzerland Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 259 Switzerland Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 260 Switzerland Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 261 Switzerland Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 262 Switzerland Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 263 Switzerland Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 264 Switzerland Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 265 Switzerland Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 266 Switzerland Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 267 Switzerland Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 268 Switzerland Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 269 Switzerland Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 270 Switzerland Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 271 Switzerland Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 272 Switzerland Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 273 Switzerland Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 274 Switzerland Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 275 Switzerland Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 276 Switzerland Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 277 Switzerland Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 278 Switzerland Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 279 Switzerland Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 280 Belgium Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 281 Belgium Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 282 Belgium Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 283 Belgium Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 284 Belgium Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 285 Belgium Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 286 Belgium Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 287 Belgium Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 288 Belgium Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 289 Belgium Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 290 Belgium Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 291 Belgium Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 292 Belgium Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 293 Belgium Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 294 Belgium Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 295 Belgium Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 296 Belgium Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 297 Belgium Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 298 Belgium Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 299 Belgium Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 300 Belgium Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 301 Belgium Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 302 Belgium Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 303 Belgium Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 304 Belgium Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 305 Turkey Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
TABLE 306 Turkey Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 307 Turkey Lung Cancer Screening Radiology Solution in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 308 Turkey Lung Cancer Screening Patient Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 309 Turkey Nodule Management Software in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 310 Turkey Data Collection and Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 311 Turkey Patient Coordination and Workflow in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 312 Turkey Lung Nodule Computer Aided Detection in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 313 Turkey Pathology and Cancer Staging in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 314 Turkey Statistical Audit Reporting in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 315 Turkey Screening PACs in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 316 Turkey Practice Management in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 317 Turkey Audit Log Tracking in Lung Cancer Screening Software Market, By Product, 2018-2027 (USD Thousand)
TABLE 318 Turkey Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 319 Turkey Computer-Assisted Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 320 Turkey Traditional Screening in Lung Cancer Screening Software Market, By Type, 2018-2027 (USD Thousand)
TABLE 321 Turkey Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 322 Turkey Non-small cell lung cancer (nsclc) in lung cancer screening software market, by application, 2018-2027 (USD Thousand)
TABLE 323 Turkey Small Cell Lung Cancer (SCLC) in Lung Cancer Screening Software Market, By Application, 2018-2027 (USD Thousand)
TABLE 324 Turkey Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 325 Turkey Standalone in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 326 Turkey Integrated in Lung Cancer Screening Software Market, By Platform, 2018-2027 (USD Thousand)
TABLE 327 Turkey Lung Cancer Screening Software Market, By Purchase Mode, 2018-2027 (USD Thousand)
TABLE 328 Turkey Lung Cancer Screening Software Market, By End User, 2018-2027 (USD Thousand)
TABLE 329 Turkey Lung Cancer Screening Software Market, By Distribution Channel, 2018-2027 (USD Thousand)
TABLE 330 REST of Asia Pacific Lung Cancer Screening Software Market, By Mode of Delivery, 2018-2027 (USD Thousand)
Lista de Figura
FIGURE 1 Europe lung cancer screening software market: segmentation
FIGURE 2 Europe lung cancer screening software market: data triangulation
FIGURE 3 Europe lung cancer screening software market: DROC ANALYSIS
FIGURE 4 Europe lung cancer screening software market: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 Europe lung cancer screening software market: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE Lung cancer screening software MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 7 Europe lung cancer screening software market: INTERVIEW DEMOGRAPHICS
FIGURE 8 Europe lung cancer screening software market: DBMR MARKET POSITION GRID
FIGURE 9 Europe lung cancer screening software market: vendor share analysis
FIGURE 10 Europe lung cancer screening software market: SEGMENTATION
FIGURE 11 RISING lung cancer screening programs and Technological advancement in THE field of healthcare is expected to drive THE Europe lung cancer screening software market IN THE FORECAST PERIOD of 2020 to 2027
FIGURE 12 Cloud based solutions segment is expected to account for the largest share of Europe lung cancer screening software market in 2020 & 2027
FIGURE 13 Drivers, RestrainTs, OPPORTUNITIES & challenges OF Europe Lung Cancer Screening Software market
FIGURE 14 Lung Cancer incidence and mortality rates, 2018
FIGURE 15 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY mode of delivery, 2019
FIGURE 16 Europe Lung cancer screening software market: BY Mode of Delivery, 2019-2027 (USD Thousand)
FIGURE 17 Europe Lung cancer screening software market: BY Mode of Delivery, CAGR (2020-2027)
FIGURE 18 Europe Lung cancer screening software market: BY Mode of Delivery, LIFELINE CURVE
FIGURE 19 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY product, 2019
FIGURE 20 Europe Lung cancer screening software market: BY product, 2019-2027 (USD Thousand)
FIGURE 21 Europe Lung cancer screening software market: BY product, CAGR (2020-2027)
FIGURE 22 Europe Lung cancer screening software market: BY product, LIFELINE CURVE
FIGURE 23 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY type, 2019
FIGURE 24 Europe Lung cancer screening software market: BY type, 2019-2027 (USD Thousand)
FIGURE 25 Europe Lung cancer screening software market: BY type, CAGR (2020-2027)
FIGURE 26 Europe Lung cancer screening software market: BY type, LIFELINE CURVE
FIGURE 27 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY application, 2019
FIGURE 28 Europe Lung cancer screening software market: BY application, 2019-2027 (USD Thousand)
FIGURE 29 Europe Lung cancer screening software market: BY application, CAGR (2020-2027)
FIGURE 30 Europe Lung cancer screening software market: BY application, LIFELINE CURVE
FIGURE 31 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY platform, 2019
FIGURE 32 Europe Lung cancer screening software market: BY platform, 2019-2027 (USD Thousand)
FIGURE 33 Europe Lung cancer screening software market: BY platform, CAGR (2020-2027)
FIGURE 34 Europe Lung cancer screening software market: BY platform, LIFELINE CURVE
FIGURE 35 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Purchase Mode, 2019
FIGURE 36 Europe Lung cancer screening software market: BY Purchase Mode, 2019-2027 (USD Thousand)
FIGURE 37 Europe Lung cancer screening software market: BY Purchase Mode, CAGR (2020-2027)
FIGURE 38 Europe Lung cancer screening software market: BY Purchase Mode, LIFELINE CURVE
FIGURE 39 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY end user, 2019
FIGURE 40 Europe Lung cancer screening software market: BY end user, 2019-2027 (USD Thousand)
FIGURE 41 Europe Lung cancer screening software market: BY end user, CAGR (2020-2027)
FIGURE 42 Europe Lung cancer screening software market: BY end user, LIFELINE CURVE
FIGURE 43 EUROPE LUNG CANCER SCREENING SOFTWARE MARKET: BY Distribution Channel, 2019
FIGURE 44 Europe Lung cancer screening software market: BY distribution channel, 2019-2027 (USD Thousand)
FIGURE 45 Europe Lung cancer screening software market: BY distribution channel, CAGR (2020-2027)
FIGURE 46 Europe Lung cancer screening software market: BY distribution channel, LIFELINE CURVE
FIGURE 47 EUROPE Lung cancer screening software MARKET: SNAPSHOT (2019)
FIGURE 48 EUROPE Lung cancer screening software MARKET: by COUNTRY (2020)
FIGURE 49 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 50 EUROPE Lung cancer screening software MARKET: by COUNTRY (2019 & 2027)
FIGURE 51 EUROPE Lung cancer screening software MARKET: by TYPE (2020-2027)
FIGURE 52 Europe Lung cancer screening software market: company share 2019 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
